Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Opus Genetics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −2 vs. Q1 2022
- Shares held
- 2.41M
- +364.6K (+17.8%) vs. Q1 2022
- Total value
- $4.62M
- −$1.99M (−30.0%) vs. Q1 2022
- New holders
- 8
- 11 more added
- Sold out
- 10
- 6 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $236.4M |
| Q1 2026 | 79 | $203.8M |
| Q4 2025 | 59 | $55.9M |
| Q3 2025 | 48 | $31.9M |
| Q2 2025 | 43 | $16.5M |
| Q1 2025 | 46 | $14.7M |
| Q4 2024 | 43 | $4.38M |
| Q3 2024 | 38 | $3.32M |
| Q2 2024 | 37 | $4.13M |
| Q1 2024 | 49 | $6.78M |
| Q4 2023 | 50 | $11.2M |
| Q3 2023 | 50 | $12.6M |
| Q2 2023 | 49 | $16.0M |
| Q1 2023 | 41 | $13.0M |
| Q4 2022 | 35 | $10.9M |
| Q3 2022 | 37 | $5.69M |
| Q2 2022 | 38 | $4.62M |
| Q1 2022 | 41 | $6.69M |
| Q4 2021 | 40 | $8.07M |
| Q3 2021 | 30 | $8.62M |
| Q2 2021 | 36 | $5.61M |
| Q1 2021 | 27 | $5.27M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Opus Genetics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 703,088 | $1.35M | 0.00% | 00.0% | Unchanged |
| Rice Hall James & Associates, LLC | 327,494 | $629.0K | 0.03% | +182,468+125.8% | Added |
| Richmond Brothers, Inc. | 311,120 | $597.0K | 0.61% | +186,576+149.8% | Added |
| Renaissance Technologies LLC | 198,190 | $381.0K | 0.00% | +198,190 | New |
| Two Sigma Advisers, LP | 152,400 | $293.0K | 0.00% | −94,200−38.2% | Reduced |
| Geode Capital Management, LLC | 147,459 | $283.0K | 0.00% | +17,535+13.5% | Added |
| BlackRock Inc. | 71,169 | $136.0K | 0.00% | +36,903+107.7% | Added |
| State Street Corp | 62,173 | $119.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 44,633 | $86.0K | 0.00% | −7,490−14.4% | Reduced |
| Millennium Management LLC | 35,582 | $68.0K | 0.00% | +35,582 | New |
| Morgan Stanley | 34,666 | $67.0K | 0.00% | +11,341+48.6% | Added |
| Diametric Capital, LP | 34,356 | $66.0K | 0.05% | −17,175−33.3% | Reduced |
| Ameriprise Financial Inc | 30,099 | $58.0K | 0.00% | +251+0.8% | Added |
| Comerica Bank | 30,000 | $58.0K | 0.00% | 00.0% | Unchanged |
| Eidelman Virant Capital | 25,000 | $48.0K | 0.03% | +25,000 | New |
| Warberg Asset Management LLC | 24,200 | $46.0K | 0.02% | +24,200 | New |
| Northern Trust Corp | 22,281 | $43.0K | 0.00% | +1,535+7.4% | Added |
| Frontier Wealth Management LLC | 18,000 | $35.0K | 0.00% | −3,000−14.3% | Reduced |
| Prelude Capital Management, LLC | 17,802 | $34.0K | 0.00% | −10,441−37.0% | Reduced |
| Citadel Advisors LLC | 16,458 | $32.0K | 0.00% | +16,458 | New |
| Charles Schwab Investment Management Inc | 14,928 | $29.0K | 0.00% | +14,928 | New |
| Cornerstone Capital, Inc. | 13,857 | $27.0K | 0.00% | +2,500+22.0% | Added |
| Stokes Family Office, LLC | 12,120 | $23.0K | 0.00% | 00.0% | Unchanged |
| MCF Advisors LLC | 10,565 | $20.0K | 0.00% | +1,066+11.2% | Added |
| Kestra Private Wealth Services, LLC | 10,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,005 | $19.0K | 0.00% | +10,005 | New |
| Spire Wealth Management | 9,002 | $17.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8,771 | $17.0K | 0.00% | +8,750+41,666.7% | Added |
| Tower Research Capital LLC (TRC) | 3,136 | $6.00K | 0.00% | +3,136 | New |
| UBS Group AG | 2,466 | $5.00K | 0.00% | −3,282−57.1% | Reduced |
| Wells Fargo & Company | 2,904 | $5.00K | 0.00% | +12+0.4% | Added |
| Captrust Financial Advisors | 1,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| CarsonAllaria Wealth Management, Ltd. | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 600 | $1.00K | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 200 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −124,021−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −51,700−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −15,600−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,600−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −16,575−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Powell Investment Advisors, LLC | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,901−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −10,243−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |